Takao Hamakubo

Tokyo, 1020084, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 100 publications

Enhanced Antitumor Efficacy of a Combination of Immunotoxin and Photosensitizer Under Illumination in Xenograft Mice.

Enhanced Antitumor Efficacy of a Combination of Immunotoxin and Photosensitizer Under Illumination in Xenograft Mice.

Journal: Biomedicines

Published: January 17, 2026

Near-infrared photochemical internalization: design of a distorted zinc phthalocyanine for efficient intracellular delivery of immunotoxins.

Near-infrared photochemical internalization: design of a distorted zinc phthalocyanine for efficient intracellular delivery of immunotoxins.

Journal: RSC medicinal chemistry

Published: November 28, 2024

Cetuximab-Toxin Conjugate and NPe6 with Light Enhanced Cytotoxic Effects in Head and Neck Squamous Cell Carcinoma In Vitro.

Cetuximab-Toxin Conjugate and NPe6 with Light Enhanced Cytotoxic Effects in Head and Neck Squamous Cell Carcinoma In Vitro.

Journal: Biomedicines

Published: March 05, 2024

Cadherin-17 as a target for the immunoPET of adenocarcinoma.

Cadherin-17 as a target for the immunoPET of adenocarcinoma.

Journal: European journal of nuclear medicine and molecular imaging

Published: November 29, 2023

Author Correction: Structure and mechanism of oxalate transporter OxlT in an oxalate-degrading bacterium in the gut microbiota.

Author Correction: Structure and mechanism of oxalate transporter OxlT in an oxalate-degrading bacterium in the gut microbiota.

Journal: Nature communications

Published: September 28, 2023

The tyrosine kinase inhibitor nintedanib enhances the efficacy of 90 Y-labeled B5209B radioimmunotherapy targeting ROBO1 without increased toxicity in small-cell lung cancer xenograft mice.

The tyrosine kinase inhibitor nintedanib enhances the efficacy of 90 Y-labeled B5209B radioimmunotherapy targeting ROBO1 without increased toxicity in small-cell lung cancer xenograft mice.

Journal: Nuclear medicine communications

Published: September 20, 2023

Inverse agonism of lysophospholipids with cationic head groups at Gi-coupled receptor GPR82.

Inverse agonism of lysophospholipids with cationic head groups at Gi-coupled receptor GPR82.

Journal: European journal of pharmacology

Published: May 11, 2023

RANK ligand converts the NCoR/HDAC3 co-repressor to a PGC1β- and RNA-dependent co-activator of osteoclast gene expression.

RANK ligand converts the NCoR/HDAC3 co-repressor to a PGC1β- and RNA-dependent co-activator of osteoclast gene expression.

Journal: Molecular cell

Published: April 03, 2023

Development of a new minimally invasive phototherapy for lung cancer using antibody-toxin conjugate.

Development of a new minimally invasive phototherapy for lung cancer using antibody-toxin conjugate.

Journal: Thoracic cancer

Published: November 09, 2022

Structure and mechanism of oxalate transporter OxlT in an oxalate-degrading bacterium in the gut microbiota.

Structure and mechanism of oxalate transporter OxlT in an oxalate-degrading bacterium in the gut microbiota.

Journal: Nature communications

Published: November 01, 2021

Wilms' tumor 1-associating protein complex regulates alternative splicing and polyadenylation at potential G-quadruplex-forming splice site sequences.

Wilms' tumor 1-associating protein complex regulates alternative splicing and polyadenylation at potential G-quadruplex-forming splice site sequences.

Journal: The Journal of biological chemistry

Published: March 15, 2021

Development of biparatopic bispecific antibody possessing tetravalent scFv-Fc capable of binding to ROBO1 expressed in hepatocellular carcinoma cells.

Development of biparatopic bispecific antibody possessing tetravalent scFv-Fc capable of binding to ROBO1 expressed in hepatocellular carcinoma cells.

Journal: Journal of biochemistry

Published: February 22, 2021

Showing 1-12 of 100

Last Updated: 09/26/2026